Published online before print July 24, 2003, doi: 10.1161/01.STR.0000083698.20199.1F
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2258.)
© 2003 American Heart Association, Inc.
Original Contributions |
Human Neural Stem Cell Transplantation Promotes Functional Recovery in Rats With Experimental Intracerebral Hemorrhage
From the Department of Neurology and Neural Stem Cell Laboratory in Clinical Research Institute, Seoul National University Hospital, and Neuroscience Research Institute of SNUMRC, Seoul, Korea (K.C., K.-H.J., M.K., J.-K.R.); Department of Neurology, Ilsan Paik Hospital, Inje University, Ilsan, Korea (S.-W.J.); and Brain Disease Research Center, Ajou University, Suwon, Korea, and Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada (S.U.K.).
Correspondence to Jae-Kyu Roh, MD, PhD, Department of Neurology, Seoul National University Hospital, 28, Yongon-Dong, Chongro-Gu, Seoul, 110-744, South Korea. E-mail rohjk{at}snu.ac.kr
Background and Purpose— Cell transplantation has been used to reduce behavioral deficit in cerebral ischemia. However, there is no report about cell transplantation in experimental intracerebral hemorrhage (ICH). We hypothesize that intravenously transplanted human neural stem cells (NSCs) can migrate and differentiate into neurons or glial cells, thereby improving functional outcome in ICH.
Methods— Experimental ICH was induced by intrastriatal administration of bacterial collagenase in adult rats. One day after surgery, the rats were randomly divided into 2 groups to receive intravenously either immortalized Lac z–positive human NSCs (5x106 cells in 500 µL, n=12) or the same amount of saline (n=13). The animals were evaluated for 8 weeks with modified limb placing and rotarod tests. Transplanted NSCs were detected by X-gal histochemistry or ß-gal immunohistochemistry with double labeling of GFAP, NeuN, neurofilament, or CNPase.
Results— Intravenously transplanted NSCs migrated selectively to the perihematomal areas and differentiated into neurons (
10% of ß-gal+ cells) and astrocytes (75%). The NSC-transplanted group showed better functional performance on rotarod test after 2 weeks and on modified limb placing test after 5 weeks compared with the control group (P<0.05), and these effects persisted for up to 8 weeks. There was no difference in the final hemispheric area between the 2 groups.
Conclusions— Intravenously transplanted NSCs can enter the rat brain with ICH, survive, migrate, and improve functional recovery. Transplantation of human NSCs can be used to restore neurological deficits in experimental ICH.
Key Words: intracerebral hemorrhage • stem cells • transplantation • rats
This article has been cited by other articles:
 |
|
 |
|
  S. Chintawar, R. Hourez, A. Ravella, D. Gall, D. Orduz, M. Rai, D. P. Bishop, S. Geuna, S. N. Schiffmann, and M. Pandolfo Grafting Neural Precursor Cells Promotes Functional Recovery in an SCA1 Mouse Model J. Neurosci., October 21, 2009; 29(42): 13126 - 13135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bacigaluppi, S. Pluchino, L. P. Jametti, E. Kilic, U. Kilic, G. Salani, E. Brambilla, M. J. West, G. Comi, G. Martino, et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms Brain, August 1, 2009; 132(8): 2239 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pluchino and G. Martino Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain Brain, March 1, 2008; 131(3): 604 - 605. [Full Text] [PDF]
|
|
|
|
|
|
S.-T. Lee, K. Chu, K.-H. Jung, S.-J. Kim, D.-H. Kim, K.-M. Kang, N. H. Hong, J.-H. Kim, J.-J. Ban, H.-K. Park, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke Brain, March 1, 2008; 131(3): 616 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bliss, R. Guzman, M. Daadi, and G. K. Steinberg Cell Transplantation Therapy for Stroke Stroke, February 1, 2007; 38(2): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Kim, S. U. Kim, I. H. Park, J. H. Bang, K. S. Aboody, K.-C. Wang, B.-K. Cho, M. Kim, L. G. Menon, P. M. Black, et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res., September 15, 2006; 12(18): 5550 - 5556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Kim, T. G. Cargioli, M. Machluf, W. Yang, Y. Sun, R. Al-Hashem, S. U. Kim, P. M. Black, and R. S. Carroll PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model Clin. Cancer Res., August 15, 2005; 11(16): 5965 - 5970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Manno, J. L. D. Atkinson, J. R. Fulgham, and E. F. M. Wijdicks Emerging Medical and Surgical Management Strategies in the Evaluation and Treatment of Intracerebral Hemorrhage Mayo Clin. Proc., March 1, 2005; 80(3): 420 - 433. [Abstract] [PDF]
|
|
|
|
|
|
NINDS ICH Workshop Participants Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop Stroke, March 1, 2005; 36(3): e23 - e41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Kim, D. S. Lee, J. H. Kang, Y. J. Lee, J.-K. Chung, J.-K. Roh, S. U. Kim, and M. C. Lee Reversing the Silencing of Reporter Sodium/Iodide Symporter Transgene for Stem Cell Tracking J. Nucl. Med., February 1, 2005; 46(2): 305 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kelly, T. M. Bliss, A. K. Shah, G. H. Sun, M. Ma, W. C. Foo, J. Masel, M. A. Yenari, I. L. Weissman, N. Uchida, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex PNAS, August 10, 2004; 101(32): 11839 - 11844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Jung, K. Chu, S.-W. Jeong, S.-Y. Han, S.-T. Lee, J.-Y. Kim, M. Kim, and J.-K. Roh HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes Sensorimotor Recovery, Suppressing Acute Inflammatory Reaction After Experimental Intracerebral Hemorrhage Stroke, July 1, 2004; 35(7): 1744 - 1749. [Abstract] [Full Text] [PDF]
|
|